According to the new market research report "Superdisintegrants Market by
Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange
Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal,
Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to
2023", published by MarketsandMarkets™,
analyzes and studies the major
market drivers, restraints/challenges, and opportunities in North America,
Europe, Asia-Pacific, and the Rest of the world (RoW).
Excipients are integral
nontherapeutic substances used for the designing and development of drugs from
active molecules which cannot be administered in the pure form. The use of
excipients helps achieve better patient compliance, dose accuracy, and consistency.
Superdisintegrants play an important role in reducing the disintegration time
of oral solid dosage forms such as tablets and capsules, thereby improving
their efficiency. Due to this advantage of superdisintegrants, these are
heavily used during the formation of orally or fast disintegrating oral
formulations, which, in turn, propel the growth of this market. These
superdisintegrants are being used in various oral dosage forms which are
further used in the treatment of neurological diseases, gastrointestinal
disease, oncology, inflammatory diseases, infectious diseases, cardiovascular
diseases, and hematological diseases. The base year considered for the study is
2017, and the forecast has been provided for the period between 2018 and 2023.
Don’t
miss out on business opportunities in Superdisintegrants Market.
Speak to our analyst and gain crucial industry insights that will help your
business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=198068672
The global superdisintegrants market is projected to
reach USD 536.5 million by 2023 from USD 366.4 billion in 2018, at a CAGR of
7.9%. Factors contributing to the growth of this market include the increasing
adoption of orally disintegrating tablets, growing generics market, and the emergence
of new superdisintegrants for the pharmaceutical industry. The shifting focus
of pharmaceutical manufacturing to emerging markets and the growth of the
overall pharmaceutical sector in these markets present significant
opportunities for the superdisintegrants market growth.
The report analyzes the global superdisintegrants
market by type, formulation, therapeutic area, and region. By type, the
synthetic superdisintegrants segment accounted for the largest share of the
market in 2017. The large share of this segment can be attributed to the
extensive consumption of these superdisintegrants in various pharmaceutical
drug formulations due to the advantages offered such as effectiveness at lower
concentrations as compared to starch and a lesser effect on the compressibility
and flowability of the dosage form.
Based on formulation, the tablets segment accounted
for the larger share of the global superdisintegrants market in 2017. The large
share of this segment can be attributed to tablets being the most widely used
dosage forms due to the benefits offered such as stability, low manufacturing
cost (as compared to other dosage forms), easy product identification, and
compactness, along with the increasing focus on orally disintegrating tablets
and fast-dissolving tablets.
Browse and in-depth
TOC on "Superdisintegrants Market "
124 – Tables
37 - Figures
182 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/superdisintegrants-market-198068672.html
124 – Tables
37 - Figures
182 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/superdisintegrants-market-198068672.html
Based
on formulation, the tablets segment accounted for the larger share of the
global superdisintegrants market in 2017. The large share of this segment can
be attributed to tablets being the most widely used dosage forms due to the
benefits offered such as stability, low manufacturing cost (as compared to
other dosage forms), easy product identification, and compactness, along with
the increasing focus on orally disintegrating tablets and fast-dissolving
tablets.
Based
on therapeutic area, the neurological diseases segment is expected to register
the highest CAGR during the forecast period. This can be attributed to the
increasing incidences of neurological disorders at the global level along with
the growing demand for effective therapies.
Request
for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=198068672
During this research study, major players operating in
the superdisintegrants market in various regions have been identified, and
their offerings, regional presence, and distribution channels have been
analyzed through in-depth discussions. Top-down and bottom-up approaches have
been used to determine the overall market size. Sizes of the other individual
markets have been estimated using the percentage splits obtained through
secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with
primary respondents. The entire procedure includes the study of the annual and
financial reports of the top market players and extensive interviews with
industry experts such as CEOs, VPs, directors, and marketing executives for key
insights (both qualitative and quantitative) pertaining to the market. The
figure below shows the breakdown of the primaries on the basis of the company
type, designation, and region considered during the research study.
Browse Adjacent
Markets @ Pharmaceuticals Market
Research Reports &
Consulting
Comments
Post a Comment